Metraipolis › archive › dc_d54fac131fb2

Real-world efficacy, safety, and associated biomarkers of cadonilimab in cervical cancer: a prospective observational study — Europe PMC PMID:42125658

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42125658
DOI: 10.3389/fimmu.2026.1723923
License (as archived): solo-consultazione
Archived: 2026-10-08T15:56:48.650Z
SHA-256 of the archived text: 08e2896e95eac9560fee7643ec4e8c5cafc4c781de4043f5b58af1e7d4d6d1e0
Stable URL of this page: https://metraipolis.com/documento/dc_d54fac131fb2

How to cite

Real-world efficacy, safety, and associated biomarkers of cadonilimab in cervical cancer: a prospective observational study — Europe PMC PMID:42125658 — Europe PMC (en), https://europepmc.org/article/MED/42125658 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d54fac131fb2 (Metraipolis archive dc_d54fac131fb2, sha256 08e2896e95eac9560fee7643ec4e8c5cafc4c781de4043f5b58af1e7d4d6d1e0)

BibTeX

@misc{dcd54fac131fb2,
  title = {Real-world efficacy, safety, and associated biomarkers of cadonilimab in cervical cancer: a prospective observational study — Europe PMC PMID:42125658},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42125658},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d54fac131fb2; sha256 08e2896e95eac9560fee7643ec4e8c5cafc4c781de4043f5b58af1e7d4d6d1e0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125658. Agents can read the archived copy with the MCP tool read_document.